Showing 1-13 of 13 results for "75-09-2"
Michele Pazzola et al.
The Journal of dairy research, 78(3), 343-348 (2011-07-22)
This study evaluated the effect of storage on renneting properties of goat milk investigated using the Formagraph method. Milk samples from 169 goats in three farms (F1, F2 and F3) were analysed during an entire lactation (45, 75, 105, 135...
Yulan Lin et al.
The British journal of nutrition, 109(10), 1873-1880 (2012-09-26)
The validity of using FFQ to assess dietary lignans is uncertain. We aimed to validate the use of FFQ for the assessment of dietary intake of lignans compared to the serum biomarker enterolactone, the main product of dietary lignans' metabolism...
Wen-ying Liang et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics, 47(3), 204-208 (2009-07-04)
To date, studies on the roles of angiopoietin-2 (ang-2) during the retinal vascular development focused on either double transgenic mice with inducible expression of ang-2 or ang-2 gene knockout mice or ang-2 gene deficient mice, and others focused on cell...
Nelly R Mugo et al.
Obstetrics and gynecology, 107(4), 807-812 (2006-04-04)
To examine the effect of human immunodeficiency virus (HIV)-1 infection on treatment outcome of laparoscopically verified acute salpingitis. Women aged 18-40 years with laparoscopically verified acute salpingitis received antibiotic therapy that included cefotetan 2 g intravenously and doxycycline 100 mg...
Jelizaveta Sokolovska et al.
Physiological reports, 8(13), e14506-e14506 (2020-07-12)
Interval walking training has demonstrated more pronounced positive effects on physical fitness and metabolism in type 2 diabetes (T2D), compared to continuous walking. One of the pathogenic mechanisms of T2D is associated with derangements in leptin/adiponectin axis, which might predispose...
L Trementino et al.
Endocrine, 50(1), 154-161 (2014-12-17)
Pasireotide is a multireceptor-targeted somatostatin analog effective in the treatment of Cushing's disease (CD). We evaluate the value of an acute pasireotide suppression test (PST) in predicting response to medium/long-term treatment in CD. Nineteen patients with active CD were prospectively...
Simon Thom et al.
JAMA, 310(9), 918-929 (2013-09-05)
Most patients with cardiovascular disease (CVD) do not take recommended medications long-term. The use of fixed-dose combinations (FDCs) improves adherence in several clinical areas. Previous trials of cardiovascular FDCs have assessed short-term effects compared with placebo or no treatment. To...
Zaen-Al-Abideen Pahore et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 21(8), 472-475 (2011-07-30)
To determine the association of JAK2V617F mutation along with BCR-ABL translocation or Philadelphia chromosome in chronic myeloid leukemia with early disease progression to advanced stages (accelerated phase or blast crisis) and poor outcome. Case series. National Institute of Blood Diseases...
Hadine Joffe et al.
JAMA internal medicine, 174(7), 1058-1066 (2014-05-28)
Estrogen therapy is the gold standard treatment for hot flashes and night sweats, but some women are unable or unwilling to use it because of associated risks. The serotonin-norepinephrine reuptake inhibitor venlafaxine hydrochloride is used widely as a nonhormonal treatment....
Helena W Rodbard et al.
The lancet. Diabetes & endocrinology, 2(1), 30-37 (2014-03-14)
We compared stepwise addition of bolus insulin with a full basal-bolus regimen in patients with type 2 diabetes inadequately controlled on basal insulin plus oral antidiabetic drugs. The FullSTEP study was a phase 4, 32-week, randomised, open-label, two-arm, parallel-group, multinational...
Tayfun Güngör et al.
Lancet (London, England), 383(9915), 436-448 (2013-10-29)
In chronic granulomatous disease allogeneic haemopoietic stem-cell transplantation (HSCT) in adolescents and young adults and patients with high-risk disease is complicated by graft-failure, graft-versus-host disease (GVHD), and transplant-related mortality. We examined the effect of a reduced-intensity conditioning regimen designed to...
Richard D Carvajal et al.
JAMA, 311(23), 2397-2405 (2014-06-19)
Uveal melanoma is characterized by mutations in GNAQ and GNA11, resulting in mitogen-activated protein kinase pathway activation. To assess the efficacy of selumetinib, a selective, non-adenosine triphosphate competitive inhibitor of MEK1 and MEK2, in uveal melanoma. Randomized, open-label, phase 2...
Lesly A Pearce et al.
The Lancet. Neurology, 13(12), 1177-1185 (2014-12-03)
The primary outcome results for the SPS3 trial suggested that a lower systolic target blood pressure (<130 mm Hg) might be beneficial for reducing the risk of recurrent stroke compared with a higher target (130-149 mm Hg), but that the...

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.